EU approves adapted Pfizer/BioNtech vaccine for COVID-19 variant

EU authorises use of adapted Pfizer/BioNtech vaccine for COVID-19 variant The European Commission has authorised an updated COVID-19 vaccine from Pfizer and its German partner BioNtech to be used in EU countries' vaccination campaigns this autumn to target the dominant Omicron XBB.1.5 variant, it said on Friday. Reuters Reuters

...

The European Medicines Authority (EMA) approved the vaccine earlier this week. EMA and the European Centre for Disease Prevention and Control recommend a single dose irrespective of vaccination history.

...